Long-term prognosis of Kawasaki disease patients with coronary artery obstruction

K Tatara1, S Kusakawa, K Itoh

  • 1Department of Pediatrics, Tokyo Women's Medical College Daini Hospital, Japan.

Heart and Vessels
|January 1, 1989
PubMed

Insights

Kawasaki disease patients with coronary artery obstruction require careful monitoring. Advanced imaging like myocardial tomography and Holter monitoring improve prognosis assessment, even in asymptomatic individuals.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Vascular Medicine

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
  • Coronary artery obstruction (CAO) is a significant complication of KD, impacting long-term prognosis.
  • Traditional methods for assessing prognosis in KD-CAO patients have limitations.

Observation:

  • A study cohort of 30 KD patients with CAO diagnosed via coronary angiography (1973-1987) was analyzed.
  • Only 26.7% of patients exhibited clinical symptoms, highlighting the challenge of early detection.
  • Clinical outcomes included mortality, chest pain, and symptomatic myocardial infarction.

Findings:

  • Treadmill stress testing detected myocardial ischemia in 31.8% of patients.
  • Thallium-201 myocardial tomography demonstrated myocardial damage in 85.7% of cases, showing superior sensitivity.
  • 24-h Holter monitoring identified frequent ventricular arrhythmias and atrioventricular blocks, associated with chest pain.

Implications:

  • Myocardial tomography offers a more accurate evaluation of myocardial damage in KD-CAO.
  • Ventricular arrhythmias represent a serious concern requiring vigilant monitoring.
  • Enhanced diagnostic tools, including myocardial tomography and Holter monitoring, are crucial for improved prognosis assessment, even in asymptomatic patients.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...